Question 1

What is the catalog number for Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit?

Accepted Answer

The catalog number for Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit is I0113.

Question 2

What sizes are available for Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit?

Accepted Answer

Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit is available in the following size(s): 96 Tests.

Question 3

Is Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit in stock?

Accepted Answer

Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 5

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Ubiquitin carboxyl-terminal hydrolase 28 (USP28) Human ELISA Kit

Product Specifications

Frequently Asked Questions

Explore Other Products

CD43 Mouse Monoclonal Antibody [A2F9]

Human Kappa Light Chain (KLC709), 0.2mg/mL

Human NT-proANP/NPPA ELISA Kit PicoKine®

Pig porcine BMP-5 ELISA Kit PicoKine®

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF405S conjugate, 0.1mg/mL

Cdc20 (AR12), 0.2mg/mL